Tumor Spectrum in Children With Noonan Syndrome and SOS1 or RAF1 Mutations

Denayer E., Devriendt K., de Ravel T., Van Buggenhout G., Smeets E., Francois I., ...Daha Fazla

GENES CHROMOSOMES & CANCER, cilt.49, sa.3, ss.242-252, 2010 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 49 Sayı: 3
  • Basım Tarihi: 2010
  • Doi Numarası: 10.1002/gcc.20735
  • Dergi Adı: GENES CHROMOSOMES & CANCER
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.242-252
  • İstanbul Üniversitesi Adresli: Evet

Özet

Noonan syndrome (NS) is an autosomal dominant disorder caused by mutations in PTPN11, KRAS, SOS1, and RAF1 We performed SOS1, RAF1, BRAF MEK1, and MEK2 mutation analysis in a cohort of 102 PTPN11- and KRAS-negative NS patients and found pathogenic SOS1 mutations in 10, RAF1 mutations in 4, and BRAF mutations in 2 patients. Three novel SOS1 mutations were found. One was classified as a rare benign variant and the other remains unclassified. We confirm a high prevalence of pulmonic stenosis and ectodermal abnormalities in SOS1-positive patients. Three patients with SOS1 mutations presented with tumors (embryonal rhabdomyosarcoma, Sertoli cell testis tumor, and granular cell tumors of the skin). One patient with a RAF1 mutation had a lesion suggestive for a giant cell tumor. This is the first report describing different tumor types in ISIS patients with germ line SOS1 mutations. (C) 2009 Wiley-Liss, Inc.